| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |